SPL 2.20% 9.3¢ starpharma holdings limited

Problem is its not been used at all in Australia on covid-19 patients.

  1. 3,250 Posts.
    lightbulb Created with Sketch. 689
    Problem is its not been used at all in Australia on covid-19 patients.

    If it was that good then why is not a single hospital that is treating covid-19 patients
    using this spray.

    No one has got better from the virus with this spray otherwise it would have made world
    headlines.

    People keep posting agreements for sales but not seen a single case of a patient
    getting better from the spray.

    I see no clinical data on a patient getting better at all.

    Testing on cells in a lab is entirely different than putting it in a human body to fight the virus.

    This this is just a bacterial spray for the nose and nothing more. Much like bactroban can be used for
    when a person has a bacterial infection they use it up the nose to control bacteria in the body as that is where
    most bacteria is and can spread out from.

    The virus gets into the lungs the spray does not do that.
    Its not like an asthma inhalers where you breath in and hold to get it into the lungs.


 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.3¢
Change
0.002(2.20%)
Mkt cap ! $37.90M
Open High Low Value Volume
9.3¢ 9.3¢ 9.2¢ $4.4K 47.75K

Buyers (Bids)

No. Vol. Price($)
2 164866 9.1¢
 

Sellers (Offers)

Price($) Vol. No.
9.3¢ 11890 2
View Market Depth
Last trade - 11.56am 24/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.